- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Di | Rio Silver, Inc.: Rio Silver Highlights High-Grade Silver up to 6.26 g/t Au and 991 g/t Ag (28.9 oz per metric tonne) over 0.70 metres at Maria Norte and Advances a Clear Near-Term Development Path in Peru | 60 | VANCOUVER, British Columbia, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Rio Silver Inc. (TSX-V: RYO | OTC: RYOOF) ("Rio Silver" or the "Company") is pleased to provide an update on its Maria Norte gold-silver-lead-zinc... ► Artikel lesen | ||
| Di | Edible Garden AG Incorporated: Edible Garden Preliminary Holiday Sales Surge 26.4% Year-Over-Year During Key Time Period | 76 | BELVIDERE, NJ, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (Nasdaq: EDBL, EDBLW), a leading provider of controlled environment agriculture (CEA)... ► Artikel lesen | ||
| Di | Anavex Life Sciences Corp.: Anavex Life Sciences Receives FDA Feedback on Alzheimer's Disease Program | 119 | NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments... ► Artikel lesen | ||
| Di | Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE) | 136 | BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% median reduction in the number of absence seizure =3s, p = 0.012DEE: 63.3%... ► Artikel lesen | ||
| Di | Alvotech announces planned CEO succession and leadership transition | 235 | R- bert Wessman to continue serving as Executive Chairman in full-time capacityLisa Graver appointed Chief Executive Officer REYKJAVIK, ICELAND (January 6, 2026) - Alvotech (NASDAQ: ALVO), a global... ► Artikel lesen | ||
| Di | SmartKem Inc.: Smartkem Signs Proof of Concept Agreement with Global Consumer Electronics Giant for MicroLED Wearables | 248 | Agreement marks validation of Smartkem's transistor technology and could lead to the introduction of a novel MicroLED display architecture to the smart wearables marketMANCHESTER, England, Jan. 06,... ► Artikel lesen | ||
| Di | LB Pharmaceuticals Inc: LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture | 801 | NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals, Inc ("LB Pharmaceuticals" or the "Company") (Nasdaq: LBRX), a clinical-stage biopharmaceutical company developing novel therapies for... ► Artikel lesen | ||
| Di | Instil Bio's Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco | 103 | DALLAS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (Nasdaq: TIL) ("Instil") today announced that Axion Bio, Inc. ("Axion"), a wholly-owned subsidiary of Instil, has decided to discontinue... ► Artikel lesen | ||
| Di | Bunker Hill Mining Corp.: Bunker Hill Enters 2026 With Strong Momentum Positioned As a New U.S. Critical Metals Producer | 226 | KELLOGG, Idaho and VANCOUVER, British Columbia, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. ("Bunker Hill" or the "Company") (TSX-V:BNKR |OTCQB:BHLL) today provided a year-end summary... ► Artikel lesen | ||
| Di | Aura Minerals Inc: Aura Announces Receipt of the Construction License and Commencement of Early Works at the Era Dorada Project | 339 |
ROAD TOWN, British Virgin Islands, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (NASDAQ: AUGO, B3: AURA33) ("Aura" or the "Company") is pleased to announce that it has received the construction... ► Artikel lesen | ||
| Di | Lithium Argentina AG: Lithium Argentina Announces 2025 Production Results for Cauchari-Olaroz and Leadership Updates | 147 | ZUG, Switzerland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Lithium Argentina AG ("Lithium Argentina" or the "Company") (TSX: LAR) (NYSE: LAR) today announced preliminary 2025 operational results for the... ► Artikel lesen | ||
| Di | Apogee Therapeutics Announces Positive Interim Results from Phase 1b Trial of Zumilokibart (APG777), its Potentially Best-in-Class Anti-IL-13 Antibody, in Patients with Mild-to-Moderate Asthma and Highlights 2026 Anticipated Milestones and ... | 88 | Phase 1b interim results of zumilokibart (APG777) in asthma demonstrated rapid and durable suppression of FeNO (key biomarker of Type 2 inflammation) through 16 weeks for all patients - Suppression... ► Artikel lesen | ||
| Di | Aclarion, Inc.: Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data | 39 | Northwestern and Scripps Health join two previously announced sites in achieving this critical patient enrollment milestone Seven leading U.S. spine centers have now completed the regulatory and operational... ► Artikel lesen | ||
| Di | G2 Goldfields Inc.: G2 Goldfields Drilling Continues to Expand High-Grade Gold Resource at OKO | 229 | Drilling intersects new gold mineralisation south of existing pit shells, including a high-grade intercept of 39.3 g/t Au over 2.7m and 2.1 g/t Au over 30m- Significant gold mineralisation intercepted... ► Artikel lesen | ||
| Di | Pzena Investment Management, LLC: Pzena Investment Management Welcomes Andrew Williams as Director of Client and Portfolio Services - UK Office | 692 | NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Pzena Investment Management ("Pzena") is pleased to announce that Andrew Williams has joined its UK office as Director of Client and Portfolio Services, reinforcing... ► Artikel lesen | ||
| Di | AnywhereNow Announces the Sale of IQ Messenger to Main Capital Partners | 515 | The sale to Main Capital Partners will drive accelerated international growth for IQ Messenger, whilst allowing AnywhereNow to focus on its core Customer Experience SaaS activities.
Rotterdam,... ► Artikel lesen | ||
| Di | Oculis Holding AG: Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis | 409 | ZUG, Switzerland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing... ► Artikel lesen | ||
| Di | Icelandair Group hf.: Record number of passengers in 2025 | 65 | In December, Icelandair transported 344 thousand passengers, up 10% year over year. During the month, 27% traveled to Iceland, 20% from Iceland, 48% via Iceland, and 6% within Iceland. In 2025, the... ► Artikel lesen | ||
| Di | Trident Resources Corp.: Trident Resources Announces Appointment of Tim J. Termuende, P.Geo as Board Chair | 290 | Vancouver, BC, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) ("Trident" or the "Company") is pleased to announce the appointment of Mr. Tim Termuende as Chairman... ► Artikel lesen | ||
| Di | SurgiBox Inc. Appoints Kelly Laurel as Chief Executive Officer | 486 | Current COO to Lead First-of-its-Kind Medical Device Company into Next Phase of Global Growth and ExpansionCAMBRIDGE, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- SurgiBox Inc., the medical technology company... ► Artikel lesen | ||
| Di | Civinity appoints Chief Operating Officer Tadas Matjošaitis to the Management Board | 35 | Civinity, a building maintenance and engineering solutions group operating in Lithuania and Latvia and one of the largest in the Baltic States, has updated the composition of its Management Board... ► Artikel lesen | ||
| Di | ING Group: Progress on share buyback programme | 255 | Progress on share buyback programme
ING announced today that, as part of our €1.1 billion share buyback programme announced on 30 October 2025, in total 1,390,645 shares were repurchased during... ► Artikel lesen | ||
| Di | TomTom: TomTom and Uber strengthen ties to enhance on-demand travel experiences globally | 89 | AMSTERDAM, Netherlands, Jan. 06, 2026 (GLOBE NEWSWIRE) -- TomTom (TOM2), the specialist in mapping and location technology, and Uber Technologies, Inc. (NYSE: UBER) have renewed their partnership... ► Artikel lesen | ||
| Di | Sampo plc's share buybacks 5 January 2026 | 208 | Sampo plc, stock exchange release, 6 January 2026 at 8:30 am EET
Sampo plc's share buybacks 5 January 2026
On 5 January 2026, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has... ► Artikel lesen | ||
| Di | Idorsia Pharmaceuticals Ltd: Idorsia initiates a proof-of-concept trial with its oral first-in-class selective CCR6 antagonist | 368 | The trial aims to establish clinical proof-of-concept in psoriasis and proof-of-mechanism for other CCR6- and Th17-associated autoimmune indications
Allschwil, Switzerland - January 6, 2026Idorsia... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .